Patientensicherheit in der Rheumatherapie: Labormonitoring bei Methotrexat

BACKGROUND: Methotrexate (MTX) is the most commonly prescribed disease-modifying drug in the treatment of rheumatic diseases. Regular laboratory testing is recommended to recognize side effects, such as hepatotoxicity and myelotoxicity as well as decreases in renal function that may cause toxic MTX...

Descripción completa

Detalles Bibliográficos
Autores principales: Sierocinski, Elizabeth, Angelow, Aniela, Mainz, Armin, Walker, Jochen, Chenot, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189943/
https://www.ncbi.nlm.nih.gov/pubmed/33709166
http://dx.doi.org/10.1007/s00393-021-00976-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189943/
https://www.ncbi.nlm.nih.gov/pubmed/33709166
http://dx.doi.org/10.1007/s00393-021-00976-7

Ejemplares similares